Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.

    

News

Cann Global Limited (ASX:CGB) Annual Report to Shareholders

🕔9/30/2019 8:20:47 AM 1074

Cann Global Ltd (ASX:CGB) ("CGB" or "the Company") presents the annual report on activities for the year ending 30 June 2019.

Read Full Article

Cann Global Limited (ASX:CGB) Asia Distribution Update

🕔9/9/2019 8:19:38 AM 1481

The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Signs Exclusive Vietnam Distributorship

🕔9/5/2019 9:31:32 AM 1502

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, have just signed an exclusive distributorship contract with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

Cann Global Limited (ASX:CGB) T12 to supply Costco

🕔8/29/2019 9:44:09 AM 1708

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, has become an official supplier to Costco.

Read Full Article

Cann Global Limited (ASX:CGB) Pharmocann Partnership Operational Update

🕔8/26/2019 9:46:08 AM 1671

Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's Nutraceutical manufacturing schedule and the Israeli based Pharmocann formulator's visit to Australia.

Read Full Article

Cann Global Limited (ASX:CGB) Reinstatement to Official Quotation - 23/08/2019

🕔8/21/2019 2:09:26 PM 1636

The suspension of trading in the securities of Cann Global Limited (ASX:CGB) is expected to lift and the Company reinstated to official quotation at the commencement of trading on Friday 23 August 2019

Read Full Article

Cann Global Limited (ASX:CGB) Reinstatement Update

🕔8/16/2019 1:35:57 PM 1626

Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.

Read Full Article

Cann Global Limited (ASX:CGB) Reinstatement Update

🕔8/9/2019 12:14:45 PM 2708

Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.

Read Full Article

Cann Global Limited (ASX:CGB) Board Changes and Directors Interest Notices

🕔8/1/2019 4:41:40 PM 1939

As foreshadowed in the Company's announcement dated 15 May 2019, Cann Global Limted (ASX:CGB) confirms that the appointments of David Austin, Jonathan Cohen and John Easterling as independent directors took effect upon approval by Shareholders at the 2 July 2019 General Meeting.

Read Full Article

Cann Global Limited (ASX:CGB) Market Update

🕔7/12/2019 8:57:32 AM 2593

Cann Global Limited (ASX:CGB) is pleased to advise that the company is in the process of providing the ASX with all the paperwork confirming completion of all the transactions, completion of all the share issues, receipt of all the required escrow agreements, and the related required relisting documentation.

Read Full Article
###

4,121 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 92) (Last 30 Days: 336) (Since Published: 4121) 

Company Data

    Headquarters
  • Level 21, 133 Castlereagh Street
    Sydney NSW 2023
    Australia
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.canngloballimited.com
  • E:
  • media@canngloballimited.com

Company Reports

Social Media